Anticancer mechanism of plumbagin, a natural compound, on non-small cell lung cancer cells.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Anticancer Research

• Publication date

  2008-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 18507021
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Radiosensitizing effects of plumbagin in cervical cancer cells is through modulation of apoptotic pathway

  2008cited by this paper
• Nuclear and cytoplasmic cellular distribution of survivin as survival predictor in resected non-small-cell lung cancer.

  2008cited by this paper
• Activation of downstream epidermal growth factor receptor (EGFR) signaling provides gefitinib‐resistance in cells carrying EGFR mutation

  2007cited by this paper
• Emergence of epidermal growth factor receptor T790M mutation during chronic exposure to gefitinib in a non small cell lung cancer cell line.

  2007cited by this paper
• p38-mediated inactivation of cyclin D1/cyclin-dependent kinase 4 stimulates nucleolar translocation of RelA and apoptosis in colorectal cancer cells.

  2007cited by this paper
• p38alpha MAP kinase as a sensor of reactive oxygen species in tumorigenesis.

  2007cited by this paper
• Cancer Statistics, 2007

  2007cited by this paper
• p38α MAP Kinase as a Sensor of Reactive Oxygen Species in Tumorigenesis

  2007cited by this paper
• Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells.

  2007cited by this paper
• Plumbagin (5-Hydroxy-2-methyl-1,4-naphthoquinone) Suppresses NF-κB Activation and NF-κB-regulated Gene Products Through Modulation of p65 and IκBα Kinase Activation, Leading to Potentiation of Apoptosis Induced by Cytokine and Chemotherapeutic Agents*

  2006cited by this paper
• Plumbagin (5-Hydroxy-2-methyl-1,4-naphthoquinone) Induces Apoptosis and Cell Cycle Arrest in A549 Cells through p53 Accumulation via c-Jun NH2-Terminal Kinase-Mediated Phosphorylation at Serine 15 in Vitro and in Vivo

  2006cited by this paper
• Plumbagin induces G2-M arrest and autophagy by inhibiting the AKT/mammalian target of rapamycin pathway in breast cancer cells

  2006cited by this paper
• JNK regulation of oncogenesis.

  2006cited by this paper
• A herbal medicine for the treatment of lung cancer

  2005cited by this paper
• Up-regulation of c-Jun-NH2-kinase pathway contributes to the induction of mitochondria-mediated apoptosis by alpha-tocopheryl succinate in human prostate cancer cells.

  2005cited by this paper
• Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery

  2005cited by this paper
• Critical update and emerging trends in epidermal growth factor receptor targeting in cancer.

  2005cited by this paper
• Regulation of MAP kinase-dependent apoptotic pathway: implication of reactive oxygen and nitrogen species.

  2005cited by this paper
• Role of JNK activation in apoptosis: A double-edged sword

  2005cited by this paper
• Investigation on Semecarpus Lehyam—a Siddha medicine for breast cancer

  2005cited by this paper
• Rasagenthi lehyam (RL) a novel complementary and alternative medicine for prostate cancer

  2004cited by this paper
• Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints.

  2004cited by this paper
• Sulforaphane-induced G2/M Phase Cell Cycle Arrest Involves Checkpoint Kinase 2-mediated Phosphorylation of Cell Division Cycle 25C*

  2004cited by this paper
• Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3

  2004cited by this paper
• Small-molecule epidermal growth factor receptor tyrosine kinase inhibitors.

  2003cited by this paper
• Bcl-2 as a target for overcoming chemoresistance in small-cell lung cancer.

  2003cited by this paper
• Selective activation of the c-Jun N-terminal kinase (JNK) pathway fails to elicit Bax activation or apoptosis unless the phosphoinositide 3′-kinase (PI3K) pathway is inhibited

  2003cited by this paper
• Synthesis of plumbagin derivatives and their inhibitory activities against Ehrlich ascites carcinoma in vivo and Leishmania donovani Promastigotes in vitro

  2002cited by this paper
• Depletion of Bcl-2 by an antisense oligonucleotide induces apoptosis accompanied by oxidation and externalization of phosphatidylserine in NCI-H226 lung carcinoma cells

  2002cited by this paper
• Upregulation of bcl‐2 is involved in the mediation of chemotherapy resistance in human small cell lung cancer cell lines

  2002cited by this paper
• Par-4, A Pro-Apoptotic Gene, Inhibits Radiation-Induced NFκB Activity and Bcl-2 Expression Leading to Induction of Radiosensitivity in Human Prostate Cancer Cells PC-3

  2002cited by this paper
• NF-kappaB signaling. Many roads lead to madrid.

  2002cited by this paper
• Akt, MAPK (Erk1/2), and p38 Act in Concert to Promote Apoptosis in Response to ErbB Receptor Family Inhibition*

  2001cited by this paper
• Cellular stress response and apoptosis in cancer therapy.

  2001cited by this paper
• Untangling the ErbB signalling network

  2001cited by this paper
• NF-Y Mediates the Transcriptional Inhibition of thecyclin B1, cyclin B2, and cdc25CPromoters upon Induced G2 Arrest*

  2001cited by this paper
• Centrosomal and cytoplasmic Cdc2/cyclin B1 activation precedes nuclear mitotic events.

  2000cited by this paper
• Identification of CIP-1-associated Regulator of Cyclin B (CARB), a Novel p21-binding Protein Acting in the G2 Phase of the Cell Cycle*

  2000cited by this paper
• The biochemistry of apoptosis

  2000cited by this paper
• Inhibition of NF-kappaB sensitizes non-small cell lung cancer cells to chemotherapy-induced apoptosis.

  2000cited by this paper
• The NF-κB Cascade Is Important in Bcl-xL Expression and for the Anti-Apoptotic Effects of the CD28 Receptor in Primary Human CD4+ Lymphocytes1

  2000cited by this paper
• Inhibition of the epidermal growth factor receptor family of tyrosine kinases as an approach to cancer chemotherapy: progression from reversible to irreversible inhibitors.

  1999cited by this paper
• The epidermal growth factor receptor and its inhibition in cancer therapy.

  1999cited by this paper
• Inhibition of the epidermal growth factor receptor family of tyrosine kinases as an approach to cancer chemotherapy: progression from reversible to irreversible inhibitors.

  1999cited by this paper
• Requirement for p53 and p21 to sustain G2 arrest after DNA damage.

  1998cited by this paper
• Genistein-induced G2-M arrest, p21WAF1 upregulation, and apoptosis in a non-small-cell lung cancer cell line.

  1998cited by this paper
• Cyclin B1 expression in response to abrogation of the radiation‐induced G2/M block in HeLa cells

  1998cited by this paper
• Pro-inflammatory signaling: last pieces in the NF-kappaB puzzle?

  1998cited by this paper
• Effect of plumbagin on the radiation induced cytogenetic and cell cycle changes in mouse Ehrlich ascites carcinoma in vivo.

  1998cited by this paper
• MEKK1/JNK signaling stabilizes and activates p53.

  1998cited by this paper
• Reduced toxicity and enhanced antitumor efficacy of betacyclodextrin plumbagin inclusion complex in mice bearing Ehrlich ascites carcinoma.

  1997cited by this paper
• Cdk2 kinase is required for entry into mitosis as a positive regulator of Cdc2-cyclin B kinase activity.

  1996cited by this paper
• Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways.

  1995cited by this paper
• A p53-independent Pathway for Activation of WAF1/CIP1 Expression Following Oxidative Stress *

  1995cited by this paper
• Epidermal growth factor-related peptides and their receptors in human malignancies.

  1995cited by this paper
• Exogenous quinones directly inhibit the respiratory NADH dehydrogenase in Escherichia coli.

  1992cited by this paper
• Plumbagin: A study of its anticancer, antibacterial & antifungal properties.

  1980cited by this paper

• The Role of Ayurveda in Prostate Cancer Management

  2025cites this paper
• Different Derivatives of Plumbagin Analogue: Bioavailability and Their Toxicity Studies

  2025cites this paper
• Four novel endolichenic fungi from Usnea spp. (Lecanorales, Parmeliaceae) in Yunnan and Guizhou, China: Taxonomic description and preliminary assessment of bioactive potentials

  2025cites this paper
• Study on the mechanism of quercetin in Sini Decoction Plus Ginseng Soup to inhibit liver cancer and HBV virus replication through CDK1

  2024cites this paper
• Synergistic Anticancer Activity of Plumbagin and Xanthohumol Combination on Pancreatic Cancer Models

  2024cites this paper
• Plumbago indica L. Root Extract Induces Anti-proliferation, Anti-migration and Apoptosis on the Human Lung Cancer Cell Line

  2024cites this paper
• Diarylheptanoid 35d overcomes EGFR TKI resistance by inducing hsp70-mediated lysosomal degradation of EGFR in EGFR-mutant lung adenocarcinoma

  2023cites this paper
• Plumbagin Suppresses Growth, Induces Apoptosis, and Inhibits Migration in Cholangiocarcinoma via Reactive Oxygen Species Generation and Mitochondrial Function

  2023cites this paper
• A review on the synthesis and application of naphthoquinone-based drugs

  2023cites this paper
• Demethoxymurrapanine, an indole‐naphthoquinone alkaloid, inhibits the proliferation of oral cancer cells without major side effects on normal cells

  2023influential citation
• Synthesis of pH-responsive covalent organic frameworks nanocarrier for plumbagin delivery

  2022cites this paper
• Structure-Activity Relationship Insight of Naturally Occurring Bioactive Molecules and Their Derivatives Against Non-Small Cell Lung Cancer: A Comprehensive Review.

  2022cites this paper
• LncRNA-ATB inhibits the proliferation and invasion of NSCLC cells by regulating MiR-200s expression

  2022cites this paper
• Current Insight into the Therapeutic Potential of Phytocompounds and their Nanoparticle-based Systems for Effective Management of Lung Cancer.

  2021cites this paper
• Plumbagin-Loaded Glycerosome Gel as Topical Delivery System for Skin Cancer Therapy

  2021cites this paper
• The effects of Benjakul extract and its isolated compounds on cell cycle arrest and apoptosis in human non-small cell lung cancer cell line NCI-H226

  2021cites this paper
• Plumbagin: A potential candidate for future research and development.

  2021cites this paper
• Establishment of adventitious root culture from leaf explants of Plumbago zeylanica: an endangered medicinal plant

  2021cites this paper
• Exploring the Potential of Medicinal Plants in Lung Cancer

  2021cites this paper
• Self-assembled metal-organic frameworks nanocrystals synthesis and application for plumbagin drug delivery in acute lung injury therapy

  2021cites this paper
• Anti-malarial drug dihydroartemisinin downregulates the expression levels of CDK1 and CCNB1 in liver cancer

  2021cites this paper
• Unmasking the potential role of plant‐based medicine “Plumbagin” in oral cancer—A Novel Paradigm

  2021cites this paper
• Plumbagin promotes mitochondrial mediated apoptosis in gefitinib sensitive and resistant A549 lung cancer cell line through enhancing reactive oxygen species generation

  2020cites this paper
• CANCER EPIGENETICS AND THE ROLE OF DIETARY ELEMENTS

  2020cites this paper
• Role of Nutrigenetics and Nutrigenomics in Cancer Chemoprevention

  2020cites this paper
• Investigation of bond topological and electrostatic properties of plumbagin molecule: An experimental and theoretical charge density study

  2020cites this paper
• Plumbagin triggers redox-mediated autophagy through the LC3B protein in human papillomavirus-positive cervical cancer cells

  2020cites this paper
• Plumbagin: A potential anti-cancer compound.

  2020cites this paper
• Pharmacotherapeutic Botanicals for Cancer Chemoprevention

  2020cites this paper
• Anti-Herpetic, Anti-Dengue and Antineoplastic Activities of Simple and Heterocycle-Fused Derivatives of Terpenyl-1,4-Naphthoquinone and 1,4-Anthraquinone

  2019cites this paper
• Anti-Proliferative Effects of Methanol and Water Extracts of Pyrrosia piloselloides on the Hela Human Cervical Carcinoma Cell Line

  2019cites this paper
• Plumbagin induces paraptosis in cancer cells by disrupting the sulfhydryl homeostasis and proteasomal function.

  2019cites this paper
• Inhibition effects of quinones on aldose reductase: Antidiabetic properties.

  2019cites this paper
• Emerging role of plumbagin: Cytotoxic potential and pharmaceutical relevance towards cancer therapy.

  2019cites this paper
• Probing the Interaction of Potent Anticancer Compound Plumbagin Isoniazid with Human Serum Albumin: Fluorescence Spectroscopy and Molecular Modelling Study

  2018cites this paper
• Plumbagin induces ROS-mediated apoptosis and cell cycle arrest and inhibits EMT in human cervical carcinoma cells

  2018cites this paper
• Chapter 16 – Chemopreventive and Anticancer Effects of Plumbagin: Novel Mechanism(s) via Modulation of Cellular Redox

  2018cites this paper
• Plumbagin suppresses the human large cell lung cancer cell lines by inhibiting IL‐6/STAT3 signaling in vitro

  2018cites this paper
• Differential gene expression induced by anti-cancer agent plumbagin is mediated by androgen receptor in prostate cancer cells

  2018cites this paper
• Oxidative stress via inhibition of the mitochondrial electron transport and Nrf-2-mediated anti-oxidative response regulate the cytotoxic activity of plumbagin

  2018cites this paper
• Discovery and cellular stress pathway analysis of 1,4-naphthoquinone derivatives with novel, highly potent broad-spectrum anticancer activity

  2018influential citation
• The inhibitory effects of plumbagin on the NF-қB pathway and CCL2 release in racially different triple-negative breast cancer cells

  2018cites this paper
• Inhibitory activities of plumbagin on cell migration and invasion and inducing activity on cholangiocarcinoma cell apoptosis

  2018cites this paper
• Plumbagin as a mutli-target drug in treatment of cancer: A review

  2017cites this paper
• Plumbagin induces apoptosis in human osteosarcoma through ROS generation, endoplasmic reticulum stress and mitochondrial apoptosis pathway.

  2017cites this paper
• Plumbagin Suppresses α-MSH-Induced Melanogenesis in B16F10 Mouse Melanoma Cells by Inhibiting Tyrosinase Activity

  2017cites this paper
• Antitumor Effect of Natural Product Molecules against Lung Cancer

  2017cites this paper
• Cytotoxic and Antioxidant Effects in Various Tissue Extracts of Plumbago zeylanica: Implications for Anticancer Potential

  2017cites this paper
• Inhibition of MDA‐MB‐231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation‐mediated p21WAF1/CIP1 expression

  2017cites this paper
• Anticancer Properties and Pharmaceutical Applications of Plumbagin: A Review.

  2017cites this paper
• Plumbagin suppresses the migration and invasion of glioma cells via downregulation of MMP-2/9 expression and inaction of PI3K/Akt signaling pathway in vitro.

  2017cites this paper
• Plumbagin reduces osteopontin-induced invasion through inhibiting the Rho-associated kinase signaling pathway in A549 cells and suppresses osteopontin-induced lung metastasis in BalB/c mice.

  2017cites this paper
• A Review on Anti-Cancerous Activity of a Bioactive Compound Plumbagin

  2017cites this paper
• Chemosuppressive effect of plumbagin on human non-small lung cancer cell xenotransplanted zebrafish.

  2017cites this paper
• The attenuating effects of plumbagin on pro-inflammatory cytokine expression in LPS-activated BV-2 microglial cells.

  2017cites this paper
• Plumbagin, a naphthaquinone derivative induces apoptosis in BRCA 1/2 defective castrate resistant prostate cancer cells as well as prostate cancer stem-like cells.

  2016cites this paper
• Nitric oxide and reactive oxygen species: Clues to target oxidative damage repair defective breast cancers.

  2016cites this paper
• Mechanism of juglone-induced apoptosis of MCF-7 cells by the mitochondrial pathway.

  2016cites this paper
• Increased sensitivity of BRCA defective triple negative breast tumors to plumbagin through induction of DNA Double Strand Breaks (DSB)

  2016cites this paper
• Nanoparticle-Based Celecoxib and Plumbagin for the Synergistic Treatment of Melanoma

  2016cites this paper
• Plumbagin shows anti-cancer activity in human breast cancer cells by the upregulation of p53 and p21 and suppression of G1 cell cycle regulators.

  2016cites this paper
• Cucurbitacin E induces caspase-dependent apoptosis and protective autophagy mediated by ROS in lung cancer cells.

  2016cites this paper
• Farnesiferol c induces apoptosis via regulation of L11 and c-Myc with combinational potential with anticancer drugs in non-small-cell lung cancers

  2016cites this paper
• In Vitro Investigation on Therapeutic Potential of Juglone, a Naphthoquinone from Walnuts against Pancreatic Cancer

  2016cites this paper
• 16-hydroxy-cleroda-3,13-dien-16,15-olide induced glioma cell autophagy via ROS generation and activation of p38 MAPK and ERK-1/2.

  2016cites this paper
• Plumbagin and Its Role in Chronic Diseases.

  2016cites this paper
• Plumbagin exerts an immunosuppressive effect on human T-cell acute lymphoblastic leukemia MOLT-4 cells.

  2016cites this paper
• Plumbagin exhibits an anti-proliferative effect in human osteosarcoma cells by downregulating FHL2 and interfering with Wnt/β-catenin signalling.

  2016cites this paper
• Plumbagin triggers DNA damage response, telomere dysfunction and genome instability of human breast cancer cells.

  2016cites this paper
• Plumbagin suppresses tumor cell growth in oral squamous cell carcinoma cell lines.

  2015cites this paper
• Plumbagin induces apoptosis in lymphoma cells via oxidative stress mediated glutathionylation and inhibition of mitogen-activated protein kinase phosphatases (MKP1/2).

  2015cites this paper
• Proteomics Analyses of Bacillus subtilis after Treatment with Plumbagin, a Plant-Derived Naphthoquinone

  2015cites this paper
• Plumbagin-silver nanoparticle formulations enhance the cellular uptake of plumbagin and its antiproliferative activities.

  2015cites this paper
• Role of adenovirus-mediated retinoblastoma 94 in the treatment of human non-small cell lung cancer

  2015cites this paper
• Toxicity evaluation of cordycepin and its delivery system for sustained in vitro anti-lung cancer activity

  2015cites this paper
• Plumbagin shows anticancer activity in human osteosarcoma (MG-63) cells via the inhibition of S-Phase checkpoints and down-regulation of c-myc.

  2015cites this paper
• Plumbagin alters telomere dynamics, induces DNA damage and cell death in human brain tumour cells.

  2015cites this paper
• α-Mangostin induces G1 cell cycle arrest in HCT116 cells through p38MAPK-p16INK4a pathway

  2015cites this paper
• “A COMPARATIVE ANTICANCER ACTIVITY OF PLUMBAGO ZEYLANICA COLLECTED FROM NORTHERN AND SOUTHERN PARTS OF INDIA”

  2015cites this paper
• Mimulone-Induced Autophagy through p53-Mediated AMPK/mTOR Pathway Increases Caspase-Mediated Apoptotic Cell Death in A549 Human Lung Cancer Cells

  2014cites this paper
• Plumbagin downregulates Wnt signaling independent of p53 in human colorectal cancer cells.

  2014cites this paper
• Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells.

  2014cites this paper
• Antiproliferative effects of Plumbago rosea and its purified constituent plumbagin on SK-MEL 28 melanoma cell lines

  2014cites this paper
• Cytotoxicity and Apoptosis Induced by a Plumbagin Derivative in Estrogen Positive MCF-7 Breast Cancer Cells

  2014cites this paper
• Plumbago rosea L. - A Review on Tissue Culture and Pharmacological Research

  2014cites this paper
• Plumbagin Modulates Leukemia Cell Redox Status

  2014cites this paper
• Role of natural phenolic compounds in cancer chemoprevention via regulation of the cell cycle.

  2014cites this paper
• Efficacy of Varunadi Ghritha (polyherbal compound) in treated head and neck cancer cases as a biological response modifier

  2014cites this paper
• Enhanced plumbagin accumulation in embryogenic cell suspension cultures of Plumbago roseaL. following elicitation

  2014cites this paper
• Anticancer Compound Plumbagin and Its Molecular Targets: A Structural Insight into the Inhibitory Mechanisms Using Computational Approaches

  2014cites this paper
• Plumbagin inhibits tumorigenesis and angiogenesis of ovarian cancer cells in vivo

  2013cites this paper
• Cytotoxic, immunomodulatory, antimycotic, and antiviral activities of semisynthetic 14-hydroxyabietane derivatives and triptoquinone C-4 epimers

  2013cites this paper
• Alternative drug therapies are superior to epidermal growth factor receptor -targeted chemotherapeutic drug responses in non-small cell lung cancer

  2013cites this paper
• Genotoxicity and interference with cell cycle activities by an ethanolic extract from Thai Plumbago indica roots in human lymphocytes in vitro.

  2013cites this paper
• The combination of plumbagin with androgen withdrawal causes profound regression of prostate tumors in vivo

  2013cites this paper
• Signal transduction in the development of pulmonary arterial hypertension

  2013cites this paper
• Plumbagin, a medicinal plant (lumbago zeylanica)‐derived 1,4‐naphthoquinone, inhibits growth and metastasis of human prostate cancer PC‐3M‐luciferase cells in an orthotopic xenograft mouse model

  2013cites this paper
• Venus Flytrap (Dionaea muscipula Solander ex Ellis) Contains Powerful Compounds that Prevent and Cure Cancer

  2013influential citation
• Quinones derived from plant secondary metabolites as anti-cancer agents.

  2013cites this paper
• The first Keystone Symposia Conference on pulmonary vascular isease and right ventricular dysfunction: Current concepts and future therapies

  2013cites this paper